EicOsis Announces Alzheimer’s Association Part the Cloud Award Supporting Phase 1b Study of EC5026 in Alzheimer's DiseaseAward to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial evaluating EicOsis' soluble epoxide hydrolase inhibitor in biomarker-confirmed early Alzheimer's disease
